Now showing items 1-2 of 2

    • Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV. 

      Alam, S Munir; Bailer, RT; Buzby, AP; Denny, Thomas Norton; Ferrari, Guido; Fischer, W; Foulds, KE; ... (32 authors) (Nature, 2014-01-23)
      A major challenge for the development of a highly effective AIDS vaccine is the identification of mechanisms of protective immunity. To address this question, we used a nonhuman primate challenge model with simian ...
    • Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. 

      Arthos, J; Bewley, CA; Bonsignori, Mattia; Boyington, JC; Burton, DR; Carrico, C; Chuang, G-Y; ... (47 authors) (Nature, 2011-11-23)
      Variable regions 1 and 2 (V1/V2) of human immunodeficiency virus-1 (HIV-1) gp120 envelope glycoprotein are critical for viral evasion of antibody neutralization, and are themselves protected by extraordinary sequence diversity ...